vs

Side-by-side financial comparison of Cheche Group Inc. (CCG) and OptimizeRx Corp (OPRX). Click either name above to swap in a different company.

Cheche Group Inc. is the larger business by last-quarter revenue ($32.8M vs $32.2M, roughly 1.0× OptimizeRx Corp). OptimizeRx Corp runs the higher net margin — 15.6% vs 0.5%, a 15.1% gap on every dollar of revenue.

Cheche Group Inc. is a leading automotive digital service provider headquartered in China. It offers integrated solutions including auto insurance intermediary services, smart auto after-sales support, and connected vehicle technology products, serving individual car owners, auto dealerships, and insurance partners across domestic and select Southeast Asian markets.

OptimizeRx Corp is a U.S.-headquartered digital health technology company that delivers patient engagement, medication affordability and clinical communication solutions to life sciences enterprises, healthcare providers and pharmacy partners. Its core offerings include digital medication savings tools, patient support programs, and therapeutic area-specific resources to boost medication access and treatment adherence.

CCG vs OPRX — Head-to-Head

Bigger by revenue
CCG
CCG
1.0× larger
CCG
$32.8M
$32.2M
OPRX
Higher net margin
OPRX
OPRX
15.1% more per $
OPRX
15.6%
0.5%
CCG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCG
CCG
OPRX
OPRX
Revenue
$32.8M
$32.2M
Net Profit
$153.6K
$5.0M
Gross Margin
5.7%
74.8%
Operating Margin
26.6%
Net Margin
0.5%
15.6%
Revenue YoY
-0.2%
Net Profit YoY
6535.9%
EPS (diluted)
$0.00
$0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCG
CCG
OPRX
OPRX
Q1 26
$32.8M
Q4 25
$32.2M
Q3 25
$26.1M
Q2 25
$26.0M
$29.2M
Q1 25
$21.9M
Q4 24
$18.6M
$32.3M
Q3 24
$21.3M
Q2 24
$36.1M
$18.8M
Net Profit
CCG
CCG
OPRX
OPRX
Q1 26
$153.6K
Q4 25
$5.0M
Q3 25
$779.0K
Q2 25
$-492.4K
$1.5M
Q1 25
$-2.2M
Q4 24
$-196.7K
$-78.0K
Q3 24
$-9.1M
Q2 24
$-7.6M
$-4.0M
Gross Margin
CCG
CCG
OPRX
OPRX
Q1 26
5.7%
Q4 25
74.8%
Q3 25
67.2%
Q2 25
4.9%
63.8%
Q1 25
60.9%
Q4 24
5.2%
68.1%
Q3 24
63.1%
Q2 24
4.3%
62.2%
Operating Margin
CCG
CCG
OPRX
OPRX
Q1 26
Q4 25
26.6%
Q3 25
7.9%
Q2 25
-2.0%
10.9%
Q1 25
-9.6%
Q4 24
-0.3%
11.2%
Q3 24
-40.2%
Q2 24
-4.7%
-19.9%
Net Margin
CCG
CCG
OPRX
OPRX
Q1 26
0.5%
Q4 25
15.6%
Q3 25
3.0%
Q2 25
-1.9%
5.2%
Q1 25
-10.0%
Q4 24
-1.1%
-0.2%
Q3 24
-42.8%
Q2 24
-21.0%
-21.3%
EPS (diluted)
CCG
CCG
OPRX
OPRX
Q1 26
$0.00
Q4 25
$0.27
Q3 25
$0.04
Q2 25
$-0.01
$0.08
Q1 25
$-0.12
Q4 24
$-0.00
$0.00
Q3 24
$-0.50
Q2 24
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCG
CCG
OPRX
OPRX
Cash + ST InvestmentsLiquidity on hand
$20.0M
$23.4M
Total DebtLower is stronger
$193.3K
$26.3M
Stockholders' EquityBook value
$128.3M
Total Assets
$203.5M
$176.9M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCG
CCG
OPRX
OPRX
Q1 26
$20.0M
Q4 25
$23.4M
Q3 25
$19.5M
Q2 25
$23.1M
$16.6M
Q1 25
$16.6M
Q4 24
$21.1M
$13.4M
Q3 24
$16.1M
Q2 24
$28.2M
Total Debt
CCG
CCG
OPRX
OPRX
Q1 26
$193.3K
Q4 25
$26.3M
Q3 25
$28.8M
Q2 25
$690.0K
$29.3M
Q1 25
$33.8M
Q4 24
$34.3M
Q3 24
$36.8M
Q2 24
$37.3M
Stockholders' Equity
CCG
CCG
OPRX
OPRX
Q1 26
Q4 25
$128.3M
Q3 25
$122.3M
Q2 25
$47.1M
$119.3M
Q1 25
$116.3M
Q4 24
$49.1M
$117.0M
Q3 24
$114.5M
Q2 24
$48.6M
$121.0M
Total Assets
CCG
CCG
OPRX
OPRX
Q1 26
$203.5M
Q4 25
$176.9M
Q3 25
$170.3M
Q2 25
$177.3M
$169.3M
Q1 25
$167.8M
Q4 24
$177.7M
$171.2M
Q3 24
$165.2M
Q2 24
$139.3M
$172.9M
Debt / Equity
CCG
CCG
OPRX
OPRX
Q1 26
Q4 25
0.20×
Q3 25
0.24×
Q2 25
0.01×
0.25×
Q1 25
0.29×
Q4 24
0.29×
Q3 24
0.32×
Q2 24
0.31×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCG
CCG
OPRX
OPRX
Operating Cash FlowLast quarter
$7.1M
Free Cash FlowOCF − Capex
$7.1M
FCF MarginFCF / Revenue
22.0%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
1.41×
TTM Free Cash FlowTrailing 4 quarters
$18.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCG
CCG
OPRX
OPRX
Q1 26
Q4 25
$7.1M
Q3 25
$3.2M
Q2 25
$-44.7M
$4.6M
Q1 25
$3.9M
Q4 24
$-15.8M
$198.0K
Q3 24
$1.8M
Q2 24
$-1.0K
$782.0K
Free Cash Flow
CCG
CCG
OPRX
OPRX
Q1 26
Q4 25
$7.1M
Q3 25
$3.2M
Q2 25
$4.6M
Q1 25
$3.8M
Q4 24
$-16.0M
$181.0K
Q3 24
$1.8M
Q2 24
$-1.1K
$737.0K
FCF Margin
CCG
CCG
OPRX
OPRX
Q1 26
Q4 25
22.0%
Q3 25
12.2%
Q2 25
15.6%
Q1 25
17.5%
Q4 24
-85.9%
0.6%
Q3 24
8.3%
Q2 24
-0.0%
3.9%
Capex Intensity
CCG
CCG
OPRX
OPRX
Q1 26
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
1.2%
0.1%
Q3 24
0.1%
Q2 24
0.0%
0.2%
Cash Conversion
CCG
CCG
OPRX
OPRX
Q1 26
Q4 25
1.41×
Q3 25
4.11×
Q2 25
2.98×
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons